Recombinant Human Glucose 1,6-bisphosphate synthase (PGM2L1), Homo sapiens (Human), Yeast, C-terminal 6xHis-tagged, 71.3kDa, purity >85% as determined by SDS-PAGE.
,

Recombinant Human Glucose 1,6-bisphosphate synthase (PGM2L1)

Recombinant Human Glucose 1,6-bisphosphate synthase (PGM2L1) — Glucose 1,6-bisphosphate synthase using 1,3-bisphosphoglycerate as a phosphate donor and a series of 1-phosphate sugars, including glucose 1-phosphate, mannose 1-phosphate, ribose 1-phosphate and d… Purity >85%.

SKU: BCRECP-001376 Categories: ,
Online Inquiry →

Product Specifications

Product SkuBCRECP-001376
Product DescriptionRecombinant Human Glucose 1,6-bisphosphate synthase (PGM2L1) Protein is expressed from Yeast with C-terminal 6xHis-tagged. It contains 1-622aa. [Accession | Q6PCE3].
Uniprot No.Q6PCE3
Gene NamesPGM2L1
PurityGreater than 85% as determined by SDS-PAGE.
Expression SystemYeast
Expression Region1-622aa
SpeciesHomo sapiens (Human)
Tag InfoC-terminal 6xHis-tagged
Molecular weight71.3kDa
ActivityPlease contact us to obtain bioactivity data.
BufferIf the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.
StorageStore at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Research AreasMetabolism

Function

Glucose 1,6-bisphosphate synthase using 1,3-bisphosphoglycerate as a phosphate donor and a series of 1-phosphate sugars, including glucose 1-phosphate, mannose 1-phosphate, ribose 1-phosphate and deoxyribose 1-phosphate, as acceptors. In vitro, also exhibits very low phosphopentomutase and phosphoglucomutase activity which are most probably not physiologically relevant.

Biological Context

Subcellular Location: Cytoplasm, cytosol
Disease Association: Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities (NEDHFS) : An autosomal recessive neurodevelopmental disorder characterized by severe developmental and speech delay, dysmorphic facial features, ear anomalies, high arched palate, strabismus, hypotonia, and keratosis pilaris. Early obesity and seizures may be present in affected individuals. [The disease is caused by variants affecting the gene represented in this entry]

Product Specifications

Recombinant Human Glucose 1,6-bisphosphate synthase (PGM2L1) is a recombinant protein from Homo sapiens (Human), expressed in Yeast, covering amino acids 1-622aa, with C-terminal 6xHis-tagged tag, molecular weight 71.3kDa, purity Greater than 85% as determined by SDS-PAGE.. Suitable for ELISA and Western Blot applications.

Recommended applications depend on the target, product format, and product-specific validation data. Refer to the product datasheet or Certificate of Analysis (CoA), or contact BioCrest Sci for application guidance.

Biological Activity: Please contact us to obtain bioactivity data.

Storage: Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

Shipping & Lead Time: Availability, shipping conditions, and estimated lead time are confirmed in the formal quotation or order confirmation based on the product format, destination, and order requirements.

Related products

Protein Biology

Function

Glucose 1,6-bisphosphate synthase using 1,3-bisphosphoglycerate as a phosphate donor and a series of 1-phosphate sugars, including glucose 1-phosphate, mannose 1-phosphate, ribose 1-phosphate and deoxyribose 1-phosphate, as acceptors (PubMed:17804405). In vitro, also exhibits very low phosphopentomutase and phosphoglucomutase activity which are most probably not physiologically relevant (PubMed:17804405)

Subcellular Location

Cytoplasm, cytosol

Disease Association

Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities (NEDHFS) : An autosomal recessive neurodevelopmental disorder characterized by severe developmental and speech delay, dysmorphic facial features, ear anomalies, high arched palate, strabismus, hypotonia, and keratosis pilaris. Early obesity and seizures may be present in affected individuals. [The disease is caused by variants affecting the gene represented in this entry]

Gene: PGM2L1  |  Organism: Homo sapiens  |  Synonyms: PMMLP; Phosphoglucomutase-2-like 1
Key Publications

Explore closely related product collections, technology platforms, and custom production resources.

Frequently Asked Questions

How do I order or inquire about this product?

Submit the Online Inquiry form with your required quantity and specifications, or email sales@biocrestsci.com. Available sizes, pricing, stock status, documentation, and estimated lead time are confirmed in the formal quotation.

What is the shipping and delivery time?

Availability, dispatch timing, shipping conditions, and delivery estimates depend on the product format, destination, and order requirements. These details are confirmed in the formal quotation or order confirmation.

How should this product be stored?

Follow the storage and handling instructions in the product-specific datasheet and Certificate of Analysis (CoA). Requirements may vary by product form and formulation; contact BioCrest Sci if product-specific guidance is needed.

What quality controls are performed on your products?

Quality-control data such as identity, purity, endotoxin level, or biological activity are provided only when specified on this product page, the datasheet, or Certificate of Analysis (CoA). Biological activity is not implied unless explicitly stated.

Shopping Cart
Scroll to Top